COVID-19严重程度与卒中:影像学与实验室标志物的相关性
这项回顾性病例系列纳入2020年3月14日至4月26日纽约市和长岛大型医疗网络中PCR阳性且影像确诊卒中的COVID-19患者,比较因重症COVID-19住院期间发生卒中者与院外起病且COVID-19症状轻微或无者,发现前者梗死更频繁、多血管分布及合并出血更多,炎症、凝血及组织损伤生物标志物更高。
要点
- 重症COVID-19住院期间发生的卒中更常表现为多血管分布梗死并合并出血。
- 该类患者C反应蛋白、铁蛋白及D-二聚体更高,淋巴细胞减少及肾肝损伤更常见。
- 作者认为考虑抗凝治疗时需谨慎平衡血栓形成与出血转化风险。
关键影像表现/征象
- 因重症COVID-19住院期间发生卒中的患者(n=41,47.7%)梗死发生率95.1%,高于院外起病且COVID-19症状轻微或无者(n=45,52.3%)的73.3%(P=.006)。
- 因重症COVID-19住院期间发生卒中的患者多血管分布梗死占56.4%,高于院外起病者的33.3%(P=.022)。
- 因重症COVID-19住院期间发生卒中的患者合并出血占31.7%,高于院外起病者的4.4%(P=.001)。
诊断标准与关键数值
- 卒中由CT和MR影像确诊,卒中亚型、梗死模式及颅内出血由2名神经放射科医生独立回顾记录。
- COVID-19阳性由聚合酶链反应检测确定。
临床应用与阅片要点
- 阅片时对因重症COVID-19住院期间发生卒中的患者注意多血管分布梗死及合并出血的表现。
- 作者认为考虑抗凝治疗时需谨慎平衡血栓形成与出血转化风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Coronavirus disease 2019 (COVID-19) appears to be an independent risk factor for stroke. We hypothesize that patients who develop stroke while hospitalized for severe COVID-19 will have higher inflammatory markers and distinct stroke imaging patterns compared with patients positive for COVID-19 with out-of-hospital stroke onset and milder or no COVID-19 symptoms.
MATERIALS AND METHODS: This is a retrospective case series of patients positive for COVID-19 on polymerase chain reaction testing with imaging-confirmed stroke treated within a large health care network in New York City and Long Island between March 14 and April 26, 2020. Clinical and laboratory data collected retrospectively included complete blood counts and creatinine, alanine aminotransferase, lactate dehydrogenase, C-reactive protein, ferritin, and D-dimer levels. All CT and MR imaging studies were independently reviewed by 2 neuroradiologists who recorded stroke subtype and patterns of infarction and intracranial hemorrhage.
RESULTS: Compared with patients with COVID-19 with outside-of-hospital stroke onset and milder or no COVID-19 symptoms (n = 45, 52.3%), patients with stroke already hospitalized for severe COVID-19 (n = 41, 47.7%) had significantly more frequent infarctions (95.1% versus 73.3%, P = .006), with multivascular distributions (56.4% versus 33.3%, P = .022) and associated hemorrhage (31.7% versus 4.4%, P = .001). Patients with stroke admitted with more severe COVID-19 had significantly higher C-reactive protein and ferritin levels, elevated D-dimer levels, and more frequent lymphopenia and renal and hepatic injury (all, P < .003).
CONCLUSIONS: Patients with stroke hospitalized with severe COVID-19 are characterized by higher inflammatory, coagulopathy, and tissue-damage biomarkers, supporting proposed pathogenic mechanisms of hyperinflammation activating a prothrombotic state. Cautious balancing of thrombosis and the risk of hemorrhagic transformation is warranted when considering anticoagulation.
引用
- Katz JM, Libman RB, Wang JJ, et al. COVID-19 Severity and Stroke: Correlation of Imaging and Laboratory Markers. AJNR Am J Neuroradiol. 2020. PMID: 33122216. doi:10.3174/ajnr.A6920
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。